Clinical trial
Efficacy and Safety of Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial
NCT07764653 is registered in ClinicalTrials.gov with HTA Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial
- Lead sponsor
- HTA Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 2, 2024
- Completion date
- June 3, 2025
- Enrollment
- 213 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, sentinel nodes